Dorzolamide and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Dorzolamide and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dorzolamide ophthalmic
Brand name: Trusopt
Synonyms: Dorzolamide ophthalmic
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dorzolamide-Moxifloxacin
- Dorzolamide-Moxifloxacin (Systemic)
- Dorzolamide-Moxifloxacin Hydrochloride
- Dorzolamide-Moxifloxacin Injection
- Dorzolamide-Moxifloxacin Intravenous
- Dorzolamide-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Dorzolamide and Timolol
- Moxetumomab pasudotox-tdfk Intravenous-Dorzolamide and Timolol Eye Drops
- Moxetumomab pasudotox-tdfk Intravenous-Dorzolamide and timolol ophthalmic
- Moxetumomab pasudotox-tdfk Intravenous-Dorzolamide and Timolol Ophthalmic Solution
- Moxetumomab pasudotox-tdfk Intravenous-Dorzolamide and Timolol Preservative-Free Eye Drops
- Moxetumomab pasudotox-tdfk Intravenous-Dorzolamide Hydrochloride